메뉴 건너뛰기




Volumn 67, Issue 2, 2016, Pages 337-340

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; END STAGE RENAL DISEASE; ERYTHROCYTE TRANSFUSION; HEALTH CARE FACILITY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MEDICARE; PATIENT CARE; PROSPECTIVE PAYMENT; REIMBURSEMENT; REVIEW; INSURANCE; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY; STANDARDS; THROMBOCYTE TRANSFUSION; TRENDS; UNITED STATES;

EID: 84965174323     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.10.002     Document Type: Article
Times cited : (9)

References (14)
  • 1
  • 2
    • 84924059652 scopus 로고    scopus 로고
    • Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?
    • M.N. Turenne, E.L. Cope, S. Porenta, and et al. Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management? J Am Soc Nephrol 26 3 2015 754 764
    • (2015) J Am Soc Nephrol , vol.26 , Issue.3 , pp. 754-764
    • Turenne, M.N.1    Cope, E.L.2    Porenta, S.3
  • 3
    • 77956005447 scopus 로고    scopus 로고
    • Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule
    • Centers for Medicare & Medicaid Services Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule Fed Regist 75 155 2010 49030 49214
    • (2010) Fed Regist , vol.75 , Issue.155 , pp. 49030-49214
  • 4
    • 84965100517 scopus 로고    scopus 로고
    • Nov. Accessed July 15, 2015
    • American Society of Nephrology. ASN Comments on ESRD PPS and QIP Final Rule Nov. 2010. http://www.asn-online.org/policy/webdocs/nov2010guidanceonfinalrule.pdf. Accessed July 15, 2015.
    • (2010) ASN Comments on ESRD PPS and QIP Final Rule
  • 5
    • 78651384385 scopus 로고    scopus 로고
    • Anemia management under a bundled payment policy for dialysis: A preview for the United States from Japan
    • J.B. Wish Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan Kidney Int 79 3 2011 265 267
    • (2011) Kidney Int , vol.79 , Issue.3 , pp. 265-267
    • Wish, J.B.1
  • 8
    • 84965161873 scopus 로고    scopus 로고
    • Claim Facility Type Code
    • Accessed July 15, 2015
    • Research Data Assistance Center. Claim Facility Type Code. Outpatient LDS Data Documentation. http://www.resdac.org/cms-data/variables/Claim-Facility-Type-Code. Accessed July 15, 2015.
    • Outpatient LDS Data Documentation
  • 9
    • 84965181107 scopus 로고    scopus 로고
    • Claim Service Classification Type Code
    • Accessed July 15, 2015
    • Research Data Assistance Center. Claim Service Classification Type Code. Outpatient LDS Data Documentation. http://www.resdac.org/cms-data/variables/Claim-Service-classification-Type-Code. Accessed July 15, 2015.
    • Outpatient LDS Data Documentation
  • 10
    • 84965168099 scopus 로고    scopus 로고
    • Claim Frequency Code
    • Accessed July 15, 2015.
    • Research Data Assistance Center. Claim Frequency Code. Outpatient LDS Data Documentation. http://www.resdac.org/cms-data/variables/Claim-Frequency-Code. Accessed July 15, 2015.
    • Outpatient LDS Data Documentation
  • 11
    • 84965115312 scopus 로고    scopus 로고
    • Revenue Center Code
    • Accessed July 15, 2015.
    • Research Data Assistance Center. Revenue Center Code. Outpatient LDS Data Documentation. http://www.resdac.org/cms-data/variables/revenue-center-code. Accessed July 15, 2015.
    • Outpatient LDS Data Documentation
  • 12
    • 84965182088 scopus 로고    scopus 로고
    • Claim Through Date
    • Accessed July 15, 2015.
    • Research Data Assistance Center. Claim Through Date. Outpatient LDS Data Documentation. http://www.resdac.org/cms-data/variables/Claim-Through-Date. Accessed July 15, 2015.
    • Outpatient LDS Data Documentation
  • 13
    • 84965139233 scopus 로고    scopus 로고
    • FDA Drug Safety Communication: Modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease
    • US Department of Health and Human Services June 24 Accessed July 15, 2015
    • US Food and Drug Administration, US Department of Health and Human Services. FDA Drug Safety Communication: modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease. Safety Announcement June 24, 2011. http://www.fda.gov/drugs/drugsafety/ucm259639.htm. Accessed July 15, 2015.
    • (2011) Safety Announcement
  • 14
    • 84856441276 scopus 로고    scopus 로고
    • Medicare Program; End-Stage Renal Disease Prospective Payment System and Quality Incentive Program; Ambulance Fee Schedule; Durable Medical Equipment; And Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies; Proposed Rule
    • Centers for Medicare & Medicaid Services (CMS), HHS Medicare Program; End-Stage Renal Disease Prospective Payment System and Quality Incentive Program; Ambulance Fee Schedule; Durable Medical Equipment; and Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies; Proposed Rule Fed Regist 76 131 2011 40498 40550
    • (2011) Fed Regist , vol.76 , Issue.131 , pp. 40498-40550


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.